HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/3/R562    most recent 00599.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Gutzwiller, J.-P. Articles by Beglinger, C. Search for Related Content PubMed PubMed Citation Articles by Gutzwiller, J.-P. Articles by Beglinger, C.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men

¹Clinical Research Center and Department of Research and ²Division of Gastroenterology, University Hospital, CH-4031 Basel, Switzerland

Submitted 15 October 2003 ; accepted in final form 14 April 2004

Glucagon-like peptide-1 (GLP-1) and CCK-33 were intravenously infused alone or in combination into normal weight men for 60 min before they were served a lunch of ham sandwiches, chocolate mousse, and orange juice. Infusion of GLP-1 (dose: 0.9 pmol·kg^–1·min^–1) or CCK-33 (dose: 0.2 pmol·kg^–1·min^–1) each reduced calorie intake of the test meal. However, simultaneous infusion of these peptide doses reduced calorie intake less than the sum of the peptides' individual effects. Infusions of the same doses of GLP-1 plus CCK-33 had neither individual nor interactive effects on meal size or calorie consumption. The combination of GLP-1 plus CCK-33 induced, however, a significant reduction in hunger feelings in the premeal period (P = 0.036 vs. all other treatments). In summary, intravenous infusion of near physiological doses of CCK-33 and GLP-1 produced specific inhibitions of hunger feeling in men; the simultaneous infusion resulted in an infra-additive reduction in calorie consumption, rejecting thereby the hypothesis that the two peptides exert a positive synergistic effect on food intake compared with the effects observed with infusion of individual peptides. In conclusion, CCK and GLP-1 are meal-related satiety signals that are released from the gastrointestinal tract during food intake.

glucagon-like peptide; cholecystokinin

This article has been cited by other articles:

				L. Degen, J. Drewe, F. Piccoli, K. Grani, S. Oesch, R. Bunea, M. D'Amato, and C. Beglinger Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1391 - R1399. [Abstract] [Full Text] [PDF]

				K. Raun, P. von Voss, C. F. Gotfredsen, V. Golozoubova, B. Rolin, and L. B. Knudsen Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not Diabetes, January 1, 2007; 56(1): 8 - 15. [Abstract] [Full Text] [PDF]

				S. Oesch, L. Degen, and C. Beglinger Effect of a protein preload on food intake and satiety feelings in response to duodenal fat perfusions in healthy male subjects Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1042 - R1047. [Abstract] [Full Text] [PDF]

				W. A. Cupples Physiological regulation of food intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1438 - R1443. [Full Text] [PDF]

				I. M. Brennan, K. L. Feltrin, M. Horowitz, A. J. P. M. Smout, J. H. Meyer, J. Wishart, and C. Feinle-Bisset Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1477 - R1485. [Abstract] [Full Text] [PDF]